Long-Term Clinical Outcomes and Correlative Efficacy Analyses in Patients (Pts) with Relapsed/Refractory Follicular Lymphoma (r/r FL) Treated with Tisagenlecleucel in the Elara Trial

Author:

Dreyling Martin1,Dickinson Michael2,Martinez Lopez Joaquin3,Kolstad Arne4,Butler Jason P5,Ghosh Monalisa6,Popplewell Leslie L.7,Chavez Julio8,Bachy Emmanuel9,Kato Koji10,Harigae Hideo11,Kersten Marie Jose1213,Andreadis Charalambos14,Riedell Peter A.15,Ho Phoebe Joy16,Perez-Simon Jose A.17,Chen Andy18,Nastoupil Loretta J.19,von Tresckow Bastian20,Ferreri Andrés J M21,Teshima Takanori22,Patten Piers E.M.2324,McGuirk Joseph P.25,Petzer Andreas26,Offner Fritz27,Viardot Andreas28,Zinzani Pier Luigi2930,Malladi Ram31,Paule Ines32,Zia Aiesha32,Awasthi Rakesh33,Han Xia34,Germano Davide32,O'Donovan Darragh35,Ramos Roberto34,Masood Aisha34,Thieblemont Catherine36,Fowler Nathan H.37,Schuster Stephen J.38

Affiliation:

1. 1Medizinische Klinik III, LMU Klinikum, Munich, Germany

2. 2Peter MacCallum Cancer Centre, Royal Melbourne Hospital and The University of Melbourne, Melbourne, Australia

3. 3Hospital 12 De Octubre, Complutense University, CNIO, Madrid, Spain

4. 4Department of Oncology, Oslo University Hospital, Radiumhospitalet, Oslo, Norway

5. 5Department of Haematology and BMT, Royal Brisbane and Women's Hospital, Brisbane, Australia

6. 6Michigan Medicine University of Michigan, Ann Arbor, MI

7. 7Department of Hematology/Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA

8. 8Moffitt Cancer Center, University of South Florida, Tampa, FL

9. 9Department of Hematology, Hospices Civils de Lyon, Lyon Sud University Hospital, Pierre Benite, France

10. 10Department of Hematology, Oncology and Cardiovascular Medicine, Kyushu University Hospital, Fukuoka, Japan

11. 11Tohoku University Hospital, Sendai, Japan

12. 12On behalf of the Lunenburg Lymphoma Phase I/II Consortium-HOVON/LLPC, Amsterdam, Netherlands, Amsterdam, Netherlands

13. 13University of Amsterdam, Amsterdam UMC, Amsterdam, Netherlands

14. 14Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA

15. 15The University of Chicago Comprehensive Cancer Center, Chicago, IL

16. 16Royal Prince Alfred Hospital and University of Sydney, Camperdown, Sydney, Australia

17. 17Instituto de Biomedicina de Sevilla (IBiS), UGC-Hematología, Hospital Universitario Virgen del Rocío/ CSIC/ CIBERONC, Universidad de Sevilla, Sevilla, Spain

18. 18Oregon Health and Science University, Portland, OR

19. 19The University of Texas MD Anderson Cancer Center, Houston, TX

20. 20Department I of Internal Medicine, West German Cancer Center Essen, Essen, Germany

21. 21Lymphoma Unit, Dept of Onco-hematology, IRCCS San Raffaele Scientific Institute, Milano, Italy

22. 22Department of Hematology, Hokkaido University Hospital, Sapporo, Japan

23. 23Comprehensive Cancer Centre, King's College London, London, United Kingdom

24. 24Department of Haematology, King's College Hospital, London, United Kingdom

25. 25Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, KS

26. 26Internal Medicine I, Ordensklinikum Linz GmbH Elisabethinen, Linz, Austria

27. 27UZ Gent, Gent, Belgium

28. 28Department of Internal Medicine III, University Hospital Ulm, Ulm, Germany

29. 29Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Università di Bologna, Bologna, Italy

30. 30IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia "Seragnoli"Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale Università di Bologna, Bologna, Italy

31. 31Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom

32. 32Novartis Pharma AG, Basel, Switzerland

33. 33Novartis Institutes for BioMedical Research, East Hanover, NJ

34. 34Novartis Pharmaceuticals Corporation, East Hanover, NJ

35. 35Novartis Pharmaceuticals Corporation, Dublin, Ireland

36. 36Hôpital Saint-Louis, Paris, France

37. 37The University of Texas, MD Anderson Cancer Center, Houston, TX

38. 38Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3